{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:59:38Z","timestamp":1762001978712,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ymgmr.2023.100982","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T17:47:50Z","timestamp":1686419270000},"page":"100982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A novel double GLA gene mutation of W24R and N419D in a patient with cardiac Fabry disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Masanori","family":"Hirose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2023.100982_bb0005","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2023.100982_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094434","article-title":"Fabry disease and the heart: a comprehensive review","volume":"22","author":"Azevedo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgmr.2023.100982_bb0015","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry's disease in men with left ventricular hypertrophy N","volume":"333","author":"Nakao","year":"1995","journal-title":"Engl. J. Med."},{"key":"10.1016\/j.ymgmr.2023.100982_bb0020","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","article-title":"Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy","volume":"105","author":"Sachdev","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ymgmr.2023.100982_bb0025","first-page":"1","article-title":"Obesity cardiomyopathy: a review of literature on clinical status and meta-analysis of diagnostic and clinical management","volume":"2","author":"Albakri","year":"2018","journal-title":"Med. Clin. Archiv."},{"key":"10.1016\/j.ymgmr.2023.100982_bb0030","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.trsl.2014.04.010","article-title":"Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management","volume":"164","author":"Alpert","year":"2014","journal-title":"Transl. Res."},{"key":"10.1016\/j.ymgmr.2023.100982_bb0035","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s12551-018-0432-5","article-title":"Anderson-Fabry disease in heart failure","volume":"10","author":"Akhtar","year":"2018","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.ymgmr.2023.100982_bb0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ymgme.2021.07.006","article-title":"Gene therapy for Fabry disease: progress, challenges, and outlooks on gene-editing","volume":"134","author":"Domm","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.100982_bb0045","first-page":"73","article-title":"Fabry disease in a Japanese population-molecular and biochemical characteristics","volume":"17","author":"Sakuraba","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2023.100982_bb0050","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/humu.10275","article-title":"Fabry disease: characterization of alpha-galactosidase a double mutations and the D313Y plasma enzyme pseudodeficiency allele","volume":"22","author":"Yasuda","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgmr.2023.100982_bb0055","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1002\/ajmg.a.37833","article-title":"Pseudo-dominant inheritance of a novel double GLA mutation associated with Fabry disease mimicking familial episodic pain","volume":"170","author":"Mao","year":"2016","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgmr.2023.100982_bb0060","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jpeds.2013.01.031","article-title":"Identification of infants at risk for developing Fabry, Pompe, or mucopolysaccharidosis-I from newborn blood spots by tandem mass spectrometry","volume":"163","author":"Scott","year":"2013","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgmr.2023.100982_bb0065","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.gene.2012.01.056","article-title":"A variant of unknown significance in the GLA gene causing diagnostic uncertainty in a young female with isolated hypertrophic cardiomyopathy","volume":"497","author":"Al-Thihli","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.ymgmr.2023.100982_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2020.105710","article-title":"Prediction of improved therapeutics for fabry disease patients generated by mutagenesis of the alpha-galactosidase a active site, dimer interface, and glycosylation region","volume":"175","author":"Stokes","year":"2020","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ymgmr.2023.100982_bb0075","article-title":"Carboxyl-terminal truncations alter the activity of the human alpha-galactosidase","volume":"10","author":"Meghdari","year":"2015","journal-title":"A PLoS One"},{"key":"10.1016\/j.ymgmr.2023.100982_bb0085","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/gim.2016.122","article-title":"The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat","volume":"19","author":"Benjamin","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgmr.2023.100982_bb0090","article-title":"The migalastat GLP-HEK assay is the gold standard for determining amenability in patients with Fabry disease","volume":"20","author":"Schiffmann","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2023.100982_bb0095","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s40265-019-01090-4","article-title":"Migalastat: a review in Fabry disease","volume":"79","author":"McCafferty","year":"2019","journal-title":"Drugs"}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426923000289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426923000289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:54:22Z","timestamp":1762001662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426923000289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":18,"alternative-id":["S2214426923000289"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2023.100982","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel double GLA gene mutation of W24R and N419D in a patient with cardiac Fabry disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2023.100982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100982"}}